APA (7th ed.) Citation

CS, W., JF, A., G, V. A., S, Z., & GJS, C. (2025). Amylin: Emergent therapeutic opportunities in overweight, obesity and diabetes mellitus. Nature reviews. Endocrinology, 21(8), 482. https://doi.org/10.1038/s41574-025-01125-9

Chicago Style (17th ed.) Citation

CS, Walker, Aitken JF, Vazhoor Amarsingh G, Zhang S, and Cooper GJS. "Amylin: Emergent Therapeutic Opportunities in Overweight, Obesity and Diabetes Mellitus." Nature Reviews. Endocrinology 21, no. 8 (2025): 482. https://doi.org/10.1038/s41574-025-01125-9.

MLA (9th ed.) Citation

CS, Walker, et al. "Amylin: Emergent Therapeutic Opportunities in Overweight, Obesity and Diabetes Mellitus." Nature Reviews. Endocrinology, vol. 21, no. 8, 2025, p. 482, https://doi.org/10.1038/s41574-025-01125-9.